Gastroenterology Research Trials

Celiac Disease can be restrictive & isolating. Do you suffer from Celiac Disease?
Celiac disease also known as gluten-sensitive enteropathy, is an immune reaction to eating gluten that is usually found in wheat, rye, or barley. This condition can be quite isolating and restrictive as people with this condition can only consume gluten-free foods.
Revive Research Institute is conducting Gastroenterology Clinical Trials for those with Celiac Disease, observing the safety and efficacy of an oral medication that may be able to help people with this condition. You may be required to consume small amounts of gluten to test the efficacy of the medication. Participation is free of cost and no insurance is required.

Do you feel difficulty in swallowing?
Eosinophilic Esophagitis is caused by the presence of a large number of eosinophils (white blood cells) in the esophagus, leading to scarring of esophagus.

If it is not treated, symptoms and inflammation can progress leading to irreversible damage to your esophagus. There are currently no therapies approved by the US Food and D  rug Administration (FDA) for Eosinophilic Esophagitis. Revive Research Institute is conducting Phase 2 Gastroenterology Research to evaluate efficacy, safety and tolerability of the study drug in adults with active Eosinophilic Esophagitis (EoE).

Are you suffering from Colorectal Cancer?
Colorectal cancer is the second leading cause of death among adults with cancer, but it doesn’t have to be. If found early, it’s one of the most preventable and treatable cancers.

Cancer screening tests, such as colonoscopy, can prevent colorectal cancer or find it early, when treatment works best. Yet 1 in 3 adults are not getting the screenings tests that could save their lives. A simple blood test that looks for early signs of colorectal cancer may make it easier for some people to be screened. Revive Research Institute is conducting clinical research to see if a simple blood test can detect colorectal cancer early, when it is easier to treat and possible to cure.

Lets Wipe Out Crohn’s
Are you tired of going to the washroom every other hour?
Revive Research Institute is conducting a Phase I-IV Clinical Trials that might be beneficial in managing your symptoms.

Our purpose of this study is to test the safety and efficacy of our drug for treating Crohn’s disease. Our experienced Gastrologist is conducting this study in Michigan along with a team of trained Gastroenterology Research staff.

Ulcerative colitis is an inflammatory bowel disease (IBD) that causes inflammation and ulcers (sores) in the digestive tract. At Revive Research Institute, our experienced gastroenterology research staff and some of the best Gastroenterologist near you are conducting Phase 3 research studies for Ulcerative Colitis patients.

The goal of the study is to determine the safety and efficacy of investigational medications when used in conjunction with routine therapy to help persons with Ulcerative Colitis heal.

Revive Research Institute is conducting Gastroenterology Clinical Research, including a Phase 2 GERD research study to help Gastroenterologist understand if an investigational drug could help people who are still unhealed even after receiving the standard treatment.

The goal of the trial is to see if using the investigational medication in combination with routine care can reduce heartburn, acid reflux and similar symptoms.

Chronic constipation is a common gastrointestinal ailment for which there is currently no effective treatment that has minimal side effects and optimal tolerability.

Researchers and Gastrologists at Revive Research Institute are making progress on a Clinical Trial for an experimental oral medication that may be able to help treat chronic constipation. The purpose of the clinical trial is to assess the drug’s safety and efficacy. To determine the success of the oral intervention and a potential treatment for constipation, our healthcare staff will continue monitoring your health and symptoms throughout the study.

Every year, approximately half a million Americans are affected by Clostridium Difficile-related disorders, generally known as deadly diarrhea. We are conducting clinical trials on an investigational medication that may be able to help treat this condition.

All participants will receive study-related care from experienced Gastrologists and research staff. If you qualify and decide to participate, you will receive study-related care and treatment free of cost to both you and your insurance.